Scott Thacher

Title: Scott Thacher: Innovator in Immune Modulation

Introduction

Scott Thacher is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of immune modulation, particularly through his innovative patents. With a total of 4 patents, Thacher's work focuses on the modulation of retinoid-related orphan receptor gamma (RORγ), which has important implications for treating inflammation and autoimmune disorders.

Latest Patents

Thacher's latest patents include methods for modulating RORγ activity. These methods involve both inhibition and stimulation of RORγ, which can lead to various beneficial effects. Inhibition of T-17 cell function and activity is crucial for treating inflammation and autoimmune disorders. Conversely, stimulation of RORγ enhances T-17 cell function, which is advantageous for developing immune-enhancing compositions, such as vaccines.

Career Highlights

Scott Thacher is currently associated with Orphagen Pharmaceuticals, where he continues to advance his research and innovations. His work is pivotal in the development of therapies aimed at improving immune responses and managing autoimmune conditions.

Collaborations

Thacher collaborates with notable colleagues, including Xiaolin Li and Robert E Babine. Their combined expertise contributes to the advancement of research in immune modulation.

Conclusion

Scott Thacher's innovative work in the modulation of RORγ activity positions him as a key figure in the field of immunology. His contributions are paving the way for new treatments that could significantly impact patient care.